DTaP vaccine adult - Baxter International
Alternative Names: AmvaxLatest Information Update: 09 Mar 2011
At a glance
- Originator Baxter International
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diphtheria; Pertussis; Tetanus
Most Recent Events
- 27 Jun 2000 North American Vaccine has been acquired by and merged into Baxter International
- 31 Dec 1998 Phase-I clinical trials for Diphtheria in Europe (Unknown route)
- 31 Dec 1998 Phase-I clinical trials for Diphtheria in USA (Unknown route)